Megan J Larsen, NP
Nurse Practitioner · Hendersonville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 25 years
- Graduated 2001
Offices
1 location · Providence Imaging Center Inc · 4 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Megan J Larsen’s office at (828) 692-6848 to ask if they take your plan before you enroll.
State licence records
1 licence
- Delaware LH-0000161Women's Health/Gender-Related NP · since 2001 · expires 2019-05-31ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$39,139
Medicare paid this office $39,139 for 205 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 75 | $8,273 | $75 |
| Long return visit (40+ min) | 47 | $8,005 | $105 |
| Short return visit (20+ min) | 129 | $7,052 | $48 |
| Blood test, basic group of blood chemicals (calcium, total) | 39 | $423 | $8 |
| Liver function blood test panel | 39 | $409 | $8 |
See all 6 services
| Return visit (30+ min) | 75 | $8,273 | $75 |
| Long return visit (40+ min) | 47 | $8,005 | $105 |
| Short return visit (20+ min) | 129 | $7,052 | $48 |
| Blood test, basic group of blood chemicals (calcium, total) | 39 | $423 | $8 |
| Liver function blood test panel | 39 | $409 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 39 | $388 | $8 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
205 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 7% · Women 100% · Also on Medicaid 5% · Health risk score 1.19. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Cancer 75% · High blood pressure 60% · Diabetes 24% · Depression 20% · Chronic kidney disease 16% · COPD 13% · Atrial fibrillation 12% · Coronary heart disease 11% · Heart failure 10% · Stroke 5%.
The office billed $141,202, Medicare allowed $52,632 and paid $39,139; for 1,871 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 205 | 1,871 | 74 | 1.19 | $141,202 | $39,139 |
| 2023 | 210 | 7,323 | 74 | 1.04 | $319,653 | $98,005 |
| 2022 | 197 | 3,506 | 74 | 1.04 | $162,720 | $49,663 |
| 2021 | 195 | 277 | 73 | 1.18 | $87,968 | $22,009 |
| 2020 | 235 | 409 | 73 | 1.19 | $126,718 | $24,365 |
| 2019 | 60 | 68 | 73 | 1.49 | $16,551 | $3,102 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 76 | $9,214 | $80 |
| Short return visit (20+ min) | 130 | $7,883 | $52 |
| Long return visit (40+ min) | 36 | $5,515 | $115 |
| Administration of chemotherapy into vein, 1 hour or less | 13 | $2,529 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 11 | $727 | $17 |
| Blood test, basic group of blood chemicals (calcium, total) | 50 | $671 | $8 |
| Advance care planning, first 30 minutes | 14 | $655 | $47 |
| Liver function blood test panel | 50 | $641 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 50 | $601 | $8 |
| Injection of additional new drug or substance into vein | 12 | $349 | $10 |
| Magnesium level | 11 | $158 | $6 |
| Insertion of needle into vein for collection of blood sample | 18 | $151 | $8 |
2022: 6 services
| Short return visit (20+ min) | 131 | $7,897 | $53 |
| Return visit (30+ min) | 68 | $7,058 | $74 |
| Long return visit (40+ min) | 33 | $4,489 | $109 |
| Blood test, basic group of blood chemicals (calcium, total) | 17 | $166 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 17 | $152 | $8 |
| Liver function blood test panel | 16 | $152 | $8 |
2021: 3 services
| Return visit (30+ min) | 99 | $11,270 | $85 |
| Short return visit (20+ min) | 95 | $5,965 | $58 |
| Long return visit (40+ min) | 33 | $4,556 | $120 |
2020: 3 services
| Return visit (30+ min) | 108 | $13,202 | $68 |
| Short return visit (20+ min) | 136 | $6,843 | $41 |
| Long return visit (40+ min) | 36 | $4,154 | $97 |
2019: 2 services
| Short return visit (20+ min) | 42 | $1,731 | $39 |
| Return visit (30+ min) | 17 | $1,073 | $63 |
Drugs they prescribed that Part D paid
$33,255
Pharmacies billed $33,255 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (18 of 607) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
568 generic and 39 brand-name prescriptions · $33,255 in drug cost · 22 antibiotic prescriptions to 15 people · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 16 | $9,138 | $571 |
| Tamoxifen Citrate | 187 | $5,128 | $27 |
| Levothyroxine | 17 | $1,476 | $87 |
| Estradiol | 28 | $1,212 | $43 |
| Letrozole | 42 | $870 | $21 |
See all 13 drugs
| Eliquis | 16 | $9,138 | $571 |
| Tamoxifen Citrate | 187 | $5,128 | $27 |
| Levothyroxine | 17 | $1,476 | $87 |
| Estradiol | 28 | $1,212 | $43 |
| Letrozole | 42 | $870 | $21 |
| Lidocaine-Prilocaine | 33 | $395 | $12 |
| Anastrozole | 15 | $329 | $22 |
| Clobetasol Propionate | 13 | $261 | $20 |
| Ondansetron | 37 | $240 | $6 |
| Fluconazole | 14 | $141 | $10 |
| Hydrocodone-Acetaminophen | 14 | $98 | $7 |
| Olanzapine | 15 | $94 | $6 |
| Gabapentin | 11 | $62 | $6 |
Year by year
| 2024 | 607 | 160 | 3% (18) | 6% | $33,255 |
| 2023 | 519 | 147 | 5% (25) | 3% | $25,296 |
| 2022 | 501 | 157 | 7% (33) | 3% | $44,104 |
| 2021 | 543 | 160 | 10% (53) | 6% | $60,275 |
| 2020 | 408 | 144 | 7% (29) | 4% | $43,042 |
| 2019 | 168 | 70 | 8% (13) | None | $3,524 |
| 2017 | 13 | None | 0% (0) | None | $838 |
| 2016 | 20 | None | 0% (0) | None | $1,688 |
| 2015 | 16 | None | None | None | $1,018 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Toremifene Citrate | 11 | $10,131 | $921 |
| Tamoxifen Citrate | 193 | $5,960 | $31 |
| Letrozole | 46 | $1,186 | $26 |
| Estradiol | 13 | $789 | $61 |
| Anastrozole | 21 | $423 | $20 |
| Lidocaine-Prilocaine | 23 | $331 | $14 |
| Fluconazole | 18 | $222 | $12 |
| Ondansetron | 21 | $215 | $10 |
| Gabapentin | 14 | $165 | $12 |
| Hydrocodone-Acetaminophen | 24 | $114 | $5 |
| Klor-Con M20 | 12 | $77 | $6 |
2022: 9 drugs
| Toremifene Citrate | 22 | $20,250 | $920 |
| Tamoxifen Citrate | 198 | $7,228 | $37 |
| Letrozole | 50 | $1,723 | $34 |
| Pregabalin | 12 | $1,612 | $134 |
| Anastrozole | 35 | $626 | $18 |
| Potassium Chloride | 12 | $448 | $37 |
| Lidocaine-Prilocaine | 17 | $292 | $17 |
| Hydrocodone-Acetaminophen | 28 | $121 | $4 |
| Ondansetron | 18 | $121 | $7 |
2021: 10 drugs
| Toremifene Citrate | 27 | $25,236 | $935 |
| Tamoxifen Citrate | 189 | $9,662 | $51 |
| Letrozole | 49 | $1,554 | $32 |
| Anastrozole | 47 | $1,525 | $32 |
| Colestipol | 16 | $1,460 | $91 |
| Lidocaine-Prilocaine | 23 | $311 | $14 |
| Ondansetron Odt | 11 | $295 | $27 |
| Ondansetron | 20 | $288 | $14 |
| Hydrocodone-Acetaminophen | 46 | $207 | $5 |
| Gabapentin | 14 | $47 | $3 |
2020: 5 drugs
| Tamoxifen Citrate | 164 | $10,904 | $66 |
| Letrozole | 65 | $2,250 | $35 |
| Anastrozole | 29 | $962 | $33 |
| Ondansetron | 11 | $224 | $20 |
| Hydrocodone-Acetaminophen | 27 | $143 | $5 |
2019: 5 drugs
| Tamoxifen Citrate | 28 | $1,401 | $50 |
| Letrozole | 42 | $832 | $20 |
| Lidocaine-Prilocaine | 19 | $274 | $14 |
| Anastrozole | 16 | $236 | $15 |
| Hydrocodone-Acetaminophen | 12 | $58 | $5 |
Money from drug and device companies
$960 in 2025
| 2025 | 14 | 40 | None | $960 |
| 2024 | 14 | 54 | None | $1,398 |
| 2023 | 14 | 51 | None | $1,351 |
| 2022 | 14 | 48 | None | $980 |
| 2021 | 12 | 52 | None | $910 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Kisqali | $174 | 7 payments
|
| Lilly USA | Verzenio | $149 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $131 | 5 payments
|
| Merck Sharp & Dohme | Keytruda | $122 | 4 payments
|
| Daiichi Sankyo | Enhertu | $105 | 4 payments
|
| Gilead Sciences | Trodelvy | $58 | 3 payments
|
See all 40 published payments
| SpringWorks Therapeutics | Meals · 2025-12-18 | Gomekli | $14 |
| Novartis Pharmaceuticals | Meals · 2025-12-09 | Kisqali | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-25 | Enhertu | $30 |
| Merck Sharp & Dohme | Meals · 2025-11-11 | Keytruda | $32 |
| Abbvie | Meals · 2025-10-28 | Elahere | $20 |
| Caris MPI | Meals · 2025-10-16 | Mi Cancer Seek | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-09 | Enhertu | $27 |
| Pfizer | Meals · 2025-09-23 | Ibrance | $21 |
| Accord Healthcare | Meals · 2025-09-09 | Camcevi | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-08 | Enhertu | $21 |
| Lilly USA | Meals · 2025-08-26 | Verzenio | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-18 | Enhertu | $25 |
| Novartis Pharmaceuticals | Meals · 2025-08-12 | Kisqali | $28 |
| Accord Healthcare | Meals · 2025-08-11 | Camcevi | $27 |
| Merck Sharp & Dohme | Meals · 2025-08-07 | Keytruda | $32 |
| Gilead Sciences | Meals · 2025-07-24 | Trodelvy | $21 |
| Novartis Pharmaceuticals | Meals · 2025-07-22 | Kisqali | $29 |
| Stemline Therapeutics | Meals · 2025-07-08 | Orserdu | $14 |
| Novartis Pharmaceuticals | Meals · 2025-06-30 | Kisqali | $6 |
| Lilly USA | Meals · 2025-06-23 | Verzenio | $19 |
| Gilead Sciences | Meals · 2025-06-19 | Trodelvy | $19 |
| Novartis Pharmaceuticals | Meals · 2025-06-17 | Kisqali | $29 |
| Lilly USA | Meals · 2025-05-29 | Verzenio | $20 |
| Daiichi Sankyo | Meals · 2025-05-22 | Enhertu | $23 |
| Gilead Sciences | Meals · 2025-05-19 | Trodelvy | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-08 | Enhertu | $28 |
| Daiichi Sankyo | Meals · 2025-05-06 | Injectafer | $23 |
| Merck Sharp & Dohme | Meals · 2025-05-05 | Keytruda | $24 |
| Lilly USA | Meals · 2025-04-29 | Verzenio | $21 |
| Novartis Pharmaceuticals | Meals · 2025-04-22 | Kisqali | $30 |
| Daiichi Sankyo | Meals · 2025-04-10 | Enhertu | $29 |
| Lilly USA | Meals · 2025-03-27 | Verzenio | $22 |
| TerSera Therapeutics | Meals · 2025-03-24 | Quzyttir | $22 |
| Daiichi Sankyo | Meals · 2025-02-25 | Enhertu | $30 |
| Lilly USA | Meals · 2025-02-24 | Verzenio | $26 |
| Novartis Pharmaceuticals | Meals · 2025-02-13 | Kisqali | $21 |
| Merck Sharp & Dohme | Meals · 2025-02-06 | Keytruda | $33 |
| Astellas Pharma US | Meals · 2025-02-04 | Veozah | $18 |
| Lilly USA | Meals · 2025-01-23 | Verzenio | $19 |
| Abbvie | Meals · 2025-01-07 | Elahere | $35 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,398
| Novartis Pharmaceuticals | Kisqali | $385 | 15 payments
|
| Daiichi Sankyo | Enhertu | $287 | 10 payments
|
| Pfizer | Adcetris | $176 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $173 | 7 payments
|
| Lilly USA | Verzenio | $125 | 6 payments
|
| Merck Sharp & Dohme | Keytruda | $81 | 3 payments
|
| Tactile Systems Technology | Flexitouch Plus | $32 | 1 payment
|
| Eisai | Lenvima | $27 | 1 payment
|
| Gilead Sciences | None | $20 | 1 payment
|
| Astellas Pharma US | Veozah | $20 | 1 payment
|
| Tempus AI | None | $20 | 1 payment
|
| Pharmacosmos Therapeutics | Cosela | $20 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $17 | 1 payment
|
| Puma Biotechnology | None | $16 | 1 payment
|
2023: $1,351
| Daiichi Sankyo | Enhertu | $376 | 12 payments
|
| Seagen | Adcetris | $257 | 5 payments
|
| Novartis Pharmaceuticals | Kisqali | $219 | 9 payments
|
| Lilly USA | Verzenio | $141 | 7 payments
|
| Merck Sharp & Dohme | Keytruda | $86 | 4 payments
|
| Tactile Systems Technology | Flexitouch Plus | $45 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $44 | 2 payments
|
| Puma Biotechnology | Nerlynx | $42 | 2 payments
|
| Gilead Sciences | None | $36 | 2 payments
|
| Stemline Therapeutics | Orserdu | $35 | 2 payments
|
| Boston Scientific | Watchman Access System | $22 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
| Pfizer | Ibrance | $16 | 1 payment
|
| Genentech USA | Perjeta | $13 | 1 payment
|
2022: $980
| Daiichi Sankyo | Enhertu | $179 | 8 payments
|
| Lilly USA | Verzenio | $142 | 8 payments
|
| Novartis Pharmaceuticals | Kisqali | $112 | 5 payments
|
| Genentech USA | Tecentriq | $104 | 1 payment
|
| Organon | Ontruzant | $79 | 5 payments
|
| Pfizer | Ibrance | $78 | 5 payments
|
| Eisai | Lenvima | $62 | 3 payments
|
| Seagen | Tukysa | $50 | 3 payments
|
| Gilead Sciences | Trodelvy | $44 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $40 | 2 payments
|
| Amgen | Xgeva | $33 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $27 | 2 payments
|
| Puma Biotechnology | Nerlynx | $15 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $14 | 1 payment
|
2021: $910
| Lilly USA | Verzenio | $283 | 12 payments
|
| Pfizer | Ibrance | $128 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $113 | 6 payments
|
| Organon | Ontruzant | $106 | 6 payments
|
| Merck Sharp & Dohme | Keytruda | $48 | 3 payments
|
| Amgen | Xgeva | $47 | 3 payments
|
| Puma Biotechnology | Nerlynx | $45 | 3 payments
|
| Tactile Systems Technology | Flexitouch Plus | $36 | 2 payments
|
| Eisai | Lenvima | $33 | 2 payments
|
| GlaxoSmithKline | Zejula | $31 | 2 payments
|
| Myriad Genetic Laboratories | Myrisk | $28 | 2 payments
|
| Stryker | Spy-Phi System | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1043231376
- Licence
- DE LH0000161, NC 5010208Delaware LH-0000161: Expired
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- DE 1000032820
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2006-07-21
- NPI last updated
- 2026-02-01
- NPI record certified
- 2026-02-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 53 S French Broad Ave, Asheville, NC, 28801